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IgA is induced through T-cell-dependent and -independent pathways. In this issue, Bunker et al. (2015) now
show that the T-cell-independent pathway is sufficient to coat most small intestinal microbes specifically,
and Fransen et al. (2015) find that IgA coating promotes uptake of microbes into Peyer’s patches and drives
further induction in a positive-feedback loop.416‘‘ButmydearSebastian. youcan’t
believe things because they’re a
lovely idea.’’‘‘But I do. That’s how I believe.’’
—Evelyn Waugh (Brideshead
Revisited)
That immunoglobulin A (IgA) generally
protects the intestinal mucosa from the
challenges of non-pathogenic members
of the intestinal microbiota is commonly
stated in immunology texts, with remark-
ably little evidence to show exactly how
this works or how extensively microbial
taxa need to be targeted. Two papers in
the current issue of Immunity now provide
some clarification of these issues (Bunker
et al., 2015; Fransen et al., 2015).
Previous studies have looked at how
IgA controls commensal bacteria. Mice
secreting monoclonal IgA from a subcu-
taneous hybridoma directed against a
single intestinal bacterium (Bacteroides
thetaiotaomicron) in RAG-deficient mice
show reduced mucosal innate immune
activation and the bacteria themselves
have less oxidative stress (Peterson
et al., 2007). Specific secretory (S)IgA
responses to single non-pathogenic
members of the microbiota generated
through T-cell-dependent or -indepen-
dent pathways (Macpherson et al., 2000)
limit penetration of high doses of intestinal
bacteria into deeper host tissues.
Such highly simplified models make the
assumption that a single microbe can be
taken as a first approximation of what
is happening in a complex microbiota
containing hundreds of different taxa.
Because is it hard to standardize such
complex microbiota even across cages
in a vivarium, the approach has often
been to compare different mouse strains
with roughly equivalent diverse intestinalImmunity 43, September 15, 2015 ª2015microbial consortia, with or without host
defects in IgA induction or secretion. For
example, the failure of IgA class switch
recombination due to a mutation in AID
(activation-induced cytidine deaminase,
G23S) reveals increased mucosal im-
mune induction through hyperplasia of
intestinal lymphoid structures and micro-
biota composition disturbances (Wei
et al., 2011), whereas targeted deletion
of the polymeric Ig receptor protein
(pIgR, responsible for IgA secretion
across epithelial cells) results in mucosal
damage and leakage of serum proteins
into the intestine (Johansen et al., 1999).
Experimental results with these
different ‘‘bottom-up’’ (simple gnotobi-
otic) and ‘‘top-down’’ (host-strain combi-
nation) approaches require the caveat
that there is a large body of evidence
that isolated deficiency of the IgA isotype
can be accommodated in both mice and
humans with remarkably few ill effects—
probably mainly because polymeric IgM
secretion can compensate for the lack of
SIgA. However, loss of all Ig isotypes
(in human common variable immunodefi-
ciency) frequently leads to serious intesti-
nal failure.
It is a truism that the hundreds of micro-
bial taxa in an intestinal microbiota
encompass a hugely diverse community
with differences in metabolism, inter-mi-
crobial interactions, niches, and potential
pathogenicity. There are good examples
of different IgA responses to particular
microbes. The earliest studies of specific
IgA were done with cholera toxin as an
immunogen that has a specific and highly
T-cell-dependent IgA response—which
protects against the secretory effects
of toxin challenge (Lycke et al., 1987).
More recently, segmented filamentous
bacteria (SFB, Candidatus arthromitus)
were shown not only to induce strongElsevier Inc.IgA responses, but also to overgrow in
the intestine if IgA was absent (Suzuki
et al., 2004). Of course, these might be
considered rather special cases: cholera
toxin because of its dramatic G protein-
coupled activation of adenylate cyclase
signaling and SFB because of its intimate
attachment to intestinal epithelial cells
in the ileum. Nevertheless, we need to
ask more generally how we should under-
stand the significance andmechanisms of
different IgA responses against diverse in-
dividual taxa within complex microbiotas.
It has long been known that, once IgA
has been transported across the epithe-
lium into the intestinal lumen, it coats the
surfaces of intestinal bacteria. Recently,
substantial progress on the significance
of IgA binding to particular taxa was
made by flow-cytometric sorting of
microbes in complex large intestinal and
fecal consortia according to the extent
of their individual IgA coating (Figure 1).
The taxa comprising those subsets of
microbes coated with IgA in vivo (and
those that have not been IgA coated)
were then identified through amplicon
sequencing of the genes for 16S ribo-
somal RNA (Palm et al., 2014). This IgA-
seq approach shows (1) that there are a
range of taxa that are preferentially
coated with IgA in vivo; (2) somemicrobes
require the T-cell-dependent IgA induc-
tion pathway whereas others are coated
with T-cell-independent IgA; and (3) if
IgA-coated microbes (derived from either
laboratory mice or human patients with
inflammatory bowel disease) are trans-
ferred into germ-free mice, it is easier to
induce experimental colitis than in ani-
mals where IgA-uncoated microbes are
transferred. The functional importance of
IgA coating in vivo has also been studied
in children with kwashiorkor protein-en-
ergy malnutrition, where fecal IgA-coated
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Figure 1. Microbial Coating with IgA along the Intestinal Tract
IgA induction occurs in the small intestine either through a T-cell-independent (TI) or a T-cell-dependent
(TD) pathway. 16S amplicon sequencing of FACS-sorted IgA-coated compared with IgA-uncoated
bacterial populations from the small intestine and colon reveal that commensal-specific IgA induced in
the small intestine can coat bacteria present in the small intestine. In contrast, in the colon only bacteria
that are also present in the small intestine are coated. Bacterial IgA coating assists uptake into lymphoid
structures and induction of further IgA.
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trigger intestinal inflammation and dys-
function when transferred into germ-free
mice (Kau et al., 2015). We can conclude
that the IgA responses of both mice and
humans are identifying sets of potentially
pathogenic microbes and that these or-
ganisms are then coated with IgA in the
intestinal lumen. Where in the intestinal
tract does this happen and what are the
cellular requirements for the response?
In this issue of Immunity, Bunker et al.
(2015) have addressed the questions of
how and where microbe-specific IgA is
induced by combining IgA-seq and host
strain combination techniques in diverselycolonized mice. They find that IgA re-
sponses to most taxa in the microbiota
can be satisfactorily induced in mice
that are doubly deficient in the beta and
delta T cell receptor (TCR) chains (thus
lacking cognate T cell help) or in mice
conditionally deficient for BCL-6 (lacking
follicular helper T cells and germinal
center formation). The presence of T cell
help makes only a small difference to
the anti-bacterial IgA repertoire, although
it does considerably amplify the magni-
tude of the response. Because it was
possible to substitute an engineered
IgG1 Fc for the IgA Fc in recombinant
monoclonal IgA antibodies from theImmunity 43, SeTcrb/d/ strain without compromising
anti-bacterial specificity, binding is prob-
ably occurring via the conventional
Fab site. There are some exceptions to
this rather promiscuous expendability
of cognate T cell help: IgA induction to
SFB and Mucispirillum, both of which
interact intimately with the epithelium
of the terminal ileum, require obligatory
TCR signaling (Figure 1).
IgA-seq has also given some new in-
sights into the dominant site of microbial
IgA induction. Whereas IgA coated a pro-
portion of most bacterial taxa in the duo-
denum, many colonic taxa were entirely
IgA negative (Bunker et al., 2015). This
highlights the importance of IgA induction
in the small intestine—exactly where the
host must limit microbial effects on the
mucosa without the aid of a developed
double mucus layer, to compete effec-
tively with its microbiota for nutrition.
What about the old issue that isolated
IgA deficiency has a very weak phenotype
in either mice or humans? A further impor-
tant result of the work by Bunker et al.
(2015) has been to show that in the
absence of IgA—in this case because of
global AID deficiency, which abolishes
both class switch recombination and so-
matic hypermutation to improve binding
affinities—IgM substituted for IgA with
corresponding binding to taxa that are
normally preferentially IgA bound. This re-
inforces the view that secreted IgM can
partially compensate for IgA deficiency
(Bunker et al., 2015).
These studies move bacterial IgA
binding from a tool that discriminates
taxa within the microbiota with potential
pathogenicity to showing that the binding
repertoire is largely unbiased in the small
intestine, whether or not induction pro-
ceeds by T-cell-dependent or T-cell-inde-
pendent means.
Just as one species of bacteria cannot
be entirely representative of the IgA
response, neither can one host genetic
background. In a second paper in
this issue of Immunity, Fransen et al.
(2015) have shown that, compared with
C57BL/6 mice that are most widely stud-
ied, BALB/c mice have higher sponta-
neous IgA secretion of natural antibodies,
even when they are germ free. These
natural antibodies promote uptake of
coated bacteria into the Peyer’s patches
(of the small intestine) and induction of
a further IgA response in an apparentptember 15, 2015 ª2015 Elsevier Inc. 417
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notion that natural specificities can have
an important effect potentially fits with
earlier experiments on the importance of
IgA in promoting mucosal antigen uptake
(Corthe´sy, 2007) and the outcome of B
cell subset transfer experiments in the
paper from Bunker et al. (2015), where
they concluded that B1 cells (but the
B1b subset rather than the B1a subset
normally associated with IgM natural
specificities) contribute to the T-cell-inde-
pendent IgA response.
Appropriately for papers in Immunity,
we are looking at the microbial dramatis
personae—who is there—determined by
the IgA response in different mouse
strains and intestinal niches. Together
they emphasize that the germline-en-
coded Ig repertoire is likely to be very
important as a starting point for host-mi-
crobial mutualism, notwithstanding clear
evidence for substantial later T-cell-
dependent diversification. Although we
can infer metabolic signatures of those418 Immunity 43, September 15, 2015 ª2015microbial taxa that are preferentially IgA
bound from their genomes, we still need
better information on how these organ-
isms actually respond to life in the intes-
tine with the challenges of nutrient and
electron acceptor limitations, bile acids,
and the consequences of quorum sensing
potentially driving symbiosis, virulence,
competence, conjugation, antibiotic pro-
duction, motility, sporulation, and biofilm
formation. We’ve come around full circle,
to a (as yet incompletely justified) belief
in the lovely idea that IgA (or IgM) actively
shapes these processes for the mutual
benefit of the host and microbiota alike.REFERENCES
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Elucidating the function of tumor-infiltrating regulatory T (Treg) cells has been difficult. In this issue of
Immunity, Joshi et al. (2015) demonstrate that Treg cells associatedwithmurine lung cancers are foundwithin
tertiary lymphoid structures and actively restrain effector T cells at the tumor site.The recent clinical success of immune-
based therapies in multiple human can-
cer types demonstrates that the immune
system can be manipulated for clinical
benefit (Page et al., 2014). This success
has triggered increased activity aimed
at understanding the inhibitory mecha-
nisms restricting anti-tumor immunity in
order to optimize clinical efficacy and
broaden the spectrum of patients who
benefit from these therapies. Front
and center in this line of inquiry are
CD4+Foxp3+ regulatory T (Treg) cells,
which are critical for the suppression of
immune responses and the maintenanceof immune homeostasis. Treg cells are
present at elevated densities in many hu-
man and murine cancers, suggesting that
these cells might play functional roles in
the tumor microenvironment. Epidemio-
logical data from human cancer studies
reveal that for some cancer types, a
high density of Treg cells within tumor
lesions is predictive of poor outcome,
whereas in other cancers, the opposite
effect is observed (deLeeuw et al.,
2012). Therefore, although it is widely
hypothesized that tumor-infiltrating Treg
cells promote tumor development by
shielding tumors from immune attack,it is equally plausible that in some can-
cer contexts, Treg cells might restrict tu-
mor development by other mechanisms,
such as suppressing tumor-promoting
inflammation. These complexities high-
light the importance of elucidating the
functional roles of tumor-infiltrating Treg
cells in different cancer types. However,
such efforts have been hampered by a
lack of approaches in tractable animal
models that enable the selective abla-
tion of Treg cells within tumor lesions
while leaving Treg cells distributed else-
where in the body untouched. In this
issue of Immunity, Joshi et al. (2015)
